Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C BORDEN

Showing results (111-120 of 327) with videos related to

Pageof 33
Sort By:
Seminars in Oncology|June 1, 1997
Increasing effectiveness of interferon-alpha for malignanciesD J Lindner, D V Kalvakolanu, E C Borden
Environmental Pollution (Barking, Essex : 1987)|May 9, 2002
MTBE and aromatic hydrocarbons in North Carolina stormwater runoffRobert C Borden, David C Black, Kathleen V McBlief
Journal of Interferon Research|April 1, 1989
Enhancement of indoleamine 2,3-dioxygenase activity in cancer patients receiving interferon-beta SerJ M Carlin, E C Borden, G I Byrne
Cancer Research|December 1, 1982
Comparative antiproliferative activity in vitro of natural interferons alpha and beta for diploid and transformed human cellsE C Borden, T F Hogan, J G Voelkel
Cancer Immunology, Immunotherapy : CII|January 1, 1982
Divergence in activation by poly I:C of human natural killer and killer cellsB S Edwards, E C Borden, K Smith-Zaremba
Investigational New Drugs|January 1, 1986
A phase II study of dihydroxyanthracenedione (DHAD, mitoxantrone, NSC 301739) in advanced malignant melanomaJ C Arseneau, D A Schoenfeld, E C Borden
The Johns Hopkins Medical Journal|February 1, 1974
Symposium on breast cancer. IntroductionE C Borden, E R Baker, M D Abeloff
Nature: New Biology|August 1, 1971
Streptovaricins inhibit focus formation by MSV (MLV) complexW A Carter, W W Brockman, E C Borden
Archives of Virology|January 1, 1981
Augmentation in the infectivity of SV40 virus DNA by amphotericin B methyl ester: brief reportE C Borden, J A McBain, J Martin, et al.
Leukemia Research|December 1, 1993
Molecular diagnosis and monitoring of leukemia and lymphomaE C Borden, J Waalen, A M Liberati, et al.
Pageof 33

Showing results (111-120 of 327) with videos related to

Sort By:
Pageof 33
Seminars in Oncology|June 1, 1997
Increasing effectiveness of interferon-alpha for malignanciesD J Lindner, D V Kalvakolanu, E C Borden
Environmental Pollution (Barking, Essex : 1987)|May 9, 2002
MTBE and aromatic hydrocarbons in North Carolina stormwater runoffRobert C Borden, David C Black, Kathleen V McBlief
Journal of Interferon Research|April 1, 1989
Enhancement of indoleamine 2,3-dioxygenase activity in cancer patients receiving interferon-beta SerJ M Carlin, E C Borden, G I Byrne
Cancer Research|December 1, 1982
Comparative antiproliferative activity in vitro of natural interferons alpha and beta for diploid and transformed human cellsE C Borden, T F Hogan, J G Voelkel
Cancer Immunology, Immunotherapy : CII|January 1, 1982
Divergence in activation by poly I:C of human natural killer and killer cellsB S Edwards, E C Borden, K Smith-Zaremba
Investigational New Drugs|January 1, 1986
A phase II study of dihydroxyanthracenedione (DHAD, mitoxantrone, NSC 301739) in advanced malignant melanomaJ C Arseneau, D A Schoenfeld, E C Borden
The Johns Hopkins Medical Journal|February 1, 1974
Symposium on breast cancer. IntroductionE C Borden, E R Baker, M D Abeloff
Nature: New Biology|August 1, 1971
Streptovaricins inhibit focus formation by MSV (MLV) complexW A Carter, W W Brockman, E C Borden
Archives of Virology|January 1, 1981
Augmentation in the infectivity of SV40 virus DNA by amphotericin B methyl ester: brief reportE C Borden, J A McBain, J Martin, et al.
Leukemia Research|December 1, 1993
Molecular diagnosis and monitoring of leukemia and lymphomaE C Borden, J Waalen, A M Liberati, et al.
Pageof 33